ro 8-0576 has been researched along with sarizotan in 1 studies
| Studies (ro 8-0576) | Trials (ro 8-0576) | Recent Studies (post-2010) (ro 8-0576) | Studies (sarizotan) | Trials (sarizotan) | Recent Studies (post-2010) (sarizotan) |
|---|---|---|---|---|---|
| 214 | 63 | 67 | 26 | 7 | 5 |
| Protein | Taxonomy | ro 8-0576 (IC50) | sarizotan (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.006 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.006 | |
| D(4) dopamine receptor | Homo sapiens (human) | 0.006 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.006 | |
| 5-hydroxytryptamine receptor 3A | Homo sapiens (human) | 0.006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egeland, M; Svenningsson, P; Zhang, X | 1 |
1 other study(ies) available for ro 8-0576 and sarizotan
| Article | Year |
|---|---|
Antidepressant-like properties of sarizotan in experimental Parkinsonism.
Topics: Animals; Antidepressive Agents; Antiparkinson Agents; Behavior, Animal; Benserazide; Cell Proliferation; Dentate Gyrus; Depression; Disease Models, Animal; Doublecortin Protein; Drug Combinations; Levodopa; Locomotion; Male; Organic Chemicals; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Swimming | 2011 |